The regulatory step in ubiquitin (Ub)-mediated protein degradation involves recognition and selection of the target substrate by an E3 Ub-ligase. E3 Ub-ligases evoke sophisticated mechanisms to regulate their activity temporally and spatially, including multiple post-translational modifications, combinatorial E3 Ub-ligase pathways, and subcellular localization. The phosphodegrons of many substrates incorporate the activities of multiple kinases, and ubiquitination only occurs when all necessary phosphorylation signals have been incorporated. In this manner, the precise timing of degradation can be controlled. Another way that the Ub pathway tightly controls the timing of proteolysis is with multiple E3 Ubligases acting upon a single target. Lastly, subcellular localization can either promote or prevent degradation by regulating the accessibility of kinases and E3 Ub-ligases. This review highlights recent findings that exemplify these emerging themes in the regulation of E3 Ub-ligase substrate recognition.
Introduction
Cellular duplication and differentiation requires mechanisms that integrate cellular growth, genomic replication, and equal nuclear division. Misregulation of any aspect of the cell cycle may understandably lead to developmental defects and diseases such as cancer. Given that the regulation of the cell cycle is so critical to an organism's well being, coordinated regulatory mechanisms have evolved to establish a specific configuration of interacting proteins that define a particular cell cycle phase or that mediate transitions between these phases. In addition to transcriptional upregulation and protein activation, targeted ubiquitin (Ub)-mediated proteolysis provides a swift and precise means by which to regulate the abundance of specific proteins and therefore the level of their activities (reviewed in Tyers and Jorgensen, 2000; Reed, 2003) . While it has been well established that targeted protein degradation is a key conduit for regulating protein levels, what is now most important is being able to understand the specific mechanisms as to how this proteolysis contributes to the regulation of cell cycle states and phase transitions.
This review aims to examine how various E3 Ubligases -which are responsible for substrate recognition in the regulatory step of the Ub-mediated proteolytic pathway -recognize their targets, and we focus on three particular emerging themes in the regulation of Ubmediated proteolysis. Using exemplary findings, we will discuss: (1) how the interaction between the E3 Ubligase and its substrate is often dependent upon phosphorylation; (2) how multiple E3 Ub-ligases are often involved in the targeting of cell cycle proteins; and (3) how the subcellular localization of substrates and E3 Ub-ligases is used to regulate proteolysis.
Ub-mediated degradation and the SCF (Skp1/Cullin/F-box) complex in cell cycle control Regulated proteolysis occurs through the Ub-mediated proteolytic pathway (reviewed in Hershko and Ciechanover, 1998) . This pathway governs the formation of a covalent multi-Ub chain, which serves as a cellular degradation signal, onto a target substrate. The ubiquitination pathway sequentially involves the E1 Ub-activating enzyme, E2 Ub-conjugating enzymes, and E3 Ub-ligases. Of particular interest is the last step of the pathway where an E3 Ub-ligase facilitates transfer of Ub -a small molecule comprised of 76-amino-acid residues -onto a lysine residue on the target substrate or onto Lys-48 of a growing Ub chain extending from the substrate. Given that this multi-Ub chain is sufficient to promote the protein's unfolding and degradation by the 26S proteasome, substrate ubiquitination must occur in a controlled and specific manner. Insight into how E3 Ub-ligases recognize specific substrates and what controls this interaction is vital for understanding the regulation of the Ub pathway.
The E3 Ub-ligases that perform the rate-limiting selectivity step of direct substrate recognition are the most numerous and varied collection in the Ub pathway. They can be classified into HECT domain, Ring-H2-finger domain, and U-box domain superfamilies Ohta et al., 1999; Seol et al., 1999; Skowyra et al., 1999; Joazeiro and Weissman, 2000; Hatakeyama et al., 2001; Fang et al., 2003; Ingham et al., 2004) . The two principal E3 Ub-ligases involved in cell cycle control are the SCF complex and the APC/C (anaphase-promoting complex/cyclosome). They are both members of the Ring-H2-finger-containing E3 Ub-ligase family. SCF complexes are used throughout the cell cycle, whereas APC functions primarily during mitosis and G1 phase.
The SCF complex has three primary subunits: Skp1, Cullin, and Rbx1/Roc1 (reviewed in Deshaies, 1999; Koepp et al., 1999) . This complex can interact with an assortment of modular F-box proteins, which all share an F-box motif that was first identified in yeast Cdc4 and cyclin F and that was shown to interact directly with Skp1 (Bai et al., 1996) . The Cul1/Rbx1 components form the E3 Ub-ligase core that associates with E2 Ubconjugating enzymes. F-box proteins directly recruit ubiquitination substrates and bridge the interaction between the E2 and the substrate (Feldman et al., 1997; Skowyra et al., 1997) . Thus, the identity of the F-box protein determines the target of the SCF. There are a variety of F-box proteins including subfamilies with WD40 domains (Fbw) or with leucine-rich repeats (Fbl) (Cenciarelli et al., 1999; Winston et al., 1999b; Jin et al., 2004) . Moreover, F-box proteins frequently recognize their substrates in a manner dependent upon particular modifications, for example, phosphorylation or glycosylation (Feldman et al., 1997; Skowyra et al., 1997; Nash et al., 2001; Yoshida et al., 2002; Orlicky et al., 2003; Wu et al., 2003) . The SCF complex itself is also subject to post-translational modifications in the form of neddylation on the Cullin subunit (Lammer et al., 1998) . Neddylation describes the linkage of Nedd8 -a small 76-residue protein with sequence similarity to Ub -to a lysine residue on the substrate. Neddylation occurs on the winged-helix B domain of Cullins, which is part of the domain that forms a globular tail binding Rbx1 and the E2-conjugating enzyme (Zheng et al., 2000; Kawakami et al., 2001) . Although Nedd8 conjugation is known to dramatically increase Ub transfer by E2's bound to the Rbx1/Cullin complex, the precise mechanism for this stimulation is unknown.
Substrate recognition by the SCF complex is dependent upon phosphorylation
Most substrates require phosphorylation to interact with the F-box protein in an SCF complex. The SCF pathway, in fact, was elucidated through efforts to understand how phosphorylation controls the abundance of cyclin and Cdk inhibitors in the Saccharomyces cerevisiae cell cycle (Bai et al., 1996; Feldman et al., 1997; Skowyra et al., 1997) . Its discovery provided a direct linkage between protein degradation and a protein kinase orchestrating the cell cycle.
Within the context of a complex cellular environment, phosphorylation allows for substrate discrimination by the SCF complex due to its ability to specifically recognize phosphorylated motifs called phosphodegrons. A phosphodegron is defined as one or a series of phosphorylated residues on the substrate that directly interact with a protein-protein interaction domain in an E3 Ub-ligase (e.g. an F-box protein), thereby linking the substrate to the conjugation machinery (Winston et al., 1999c; Nash et al., 2001) . Additionally, phosphorylation allows temporal regulation of substrate degradation, even if SCF complexes are constitutively active throughout the cell cycle.
The best characterized example of phosphodegron utilization involves the G1/S transition in S. cerevisiae, where the WD40 propeller structure of the F-box protein Cdc4p recognizes sequences in Sic1p after their phosphorylation by Cln1/2-Cdc28 kinases (Nash et al., 2001; Orlicky et al., 2003) . Sic1p is a Cdk inhibitor, and its degradation frees Cln5/6-Cdc28 to initiate DNA replication. Sic1p contains as many as nine Cdk phosphorylation sites, which individually bind weakly to Cdc4p. However, upon phosphorylation of a minimum of six Cdk sites, Sic1p is efficiently recognized by Cdc4p, ubiquitinated, and degraded (Nash et al., 2001) . In this manner, Sic1p acts as a gauge for Cln-Cdc28 activity by accumulating phosphates until a threshold number of phosphorylation events promotes its turnover (Deshaies and Ferrell, 2001; Harper, 2002) . Moreover, suboptimal phosphorylation sites confer ultrasensitivity to the system, as individual Sic1 proteins 'resist' ubiquitination when Cln-Cdc28 activity is increasing, but still too low to signal for Sic1p to release Clb-Cdc28 from inhibition. Thus, the system avoids 'noise' or premature Clb-Cdc28 activation, and instead creates a switch-like transition where Clb-Cdc28 will be activated in a uniform manner.
In the case of Sic1p, phosphorylation by kinase ClnCdc28 appears to be sufficient for recognition by Cdc4p. In contrast, many targets of mammalian SCF complexes require a complex interplay between multiple kinases or kinase pathways in order to generate the requisite phosphodegron on the SCF target. For example, SCF b-TRCP substrates IkBa, b-catenin, Emi1 (early mitotic inhibitor 1), Cdc25A, and Wee1 require the combined activities of multiple kinases to create their phosphodegron motifs (Figure 1) (Winston et al., 1999c; Liu et al., 2002; Margottin-Goguet et al., 2003; Watanabe et al., 2004) . Early studies identified a small peptide motif (i.e. phosphodegron) on both IkBa and b-catenin that was able to bind to b-TRCP in a phosphorylation-dependent manner (Winston et al., 1999c) . The motif or a closely related sequence (DpSGFXpS, where F is a hydrophobic amino acid and pS is phosphoserine) has been found to be involved in the majority of SCF b-TRCP substrates. In these cases, dual phosphorylation within the motif is important for high-affinity binding. With IkK, a kinase complex containing both I-kappa kinase a and I-kappa kinase b is required for proper IkBa phosphorylation on Ser-32 and Ser-36 to create the phosphodegron. In contrast, generation of the analogous phosphorylation event in b-catenin by GSK3b requires prior phosphorylation by casein kinase 1, which serves as a priming enzyme for GSK3b (Figure 1 ). However, recent work suggests that b-TRCP has the capability to bind to noncanonical phosphodegrons. One such example is found with the cell cycle regulator Cdc25A. In response to DNA damage, Cdc25A is targeted for destruction by a pathway that depends upon the Chk1 kinase and b-TRCP (Busino et al., 2003; . Phosphorylation by Chk1 is thought to prime Cdc25A for phosphorylation by a yet unidentified kinase on nearby residues to create the EpSTDpSGF phosphodegron, with Ser-79 and Ser-82 being phosphorylated . Thus, the phosphorylation site following the DSG tripeptide is missing in the Cdc25A degron. Currently, it is unclear whether Ser-79 phosphorylation is required for interaction of Cdc25A with b-TRCP or is simply required for phosphorylation of Ser-82, although studies with synthetic peptides indicate that phosphorylation at neither Ser-76 (Chk1 site) nor Ser-79 is absolutely required for binding to b-TRCP. In addition, Wee1 employs a related EDpSAF sequence but, like Cdc25A, lacks the second phosphoserine (Watanabe et al., 2004) . This phosphorylation event is carried out by polo-kinase 1 (Plk1) in a manner that appears to depend upon prior phosphorylation of Ser-123 by Cdc2. It is possible that phospho-Ser-123 is directly involved in the interaction with b-TRCP or, more likely, phosphorylation at this site provides a platform for binding of Plk1 to Wee1 through its polo-box, which binds to Cdc2 consensus sites. Like Wee1, Emi1 is also targeted for degradation by the combined action of Cdc2 and Plk1, as discussed below (Hansen et al., 2004; Moshe et al., 2004) . Additional examples of dual phosphorylation mechanisms are discussed below with respect to targets of the SCF Fbw7 complex. There are many implications to having a degron undergo multiple phosphorylations by distinct kinases. First, such a phosphodegron has the capacity of integrating multiple input signals into a single molecule that can serve as a read out for the status of upstream pathways. The cell likely has to monitor many different events and environmental cues throughout its cycle such as the successful completion of mitotic checkpoints or whether its environment contains sufficient nutrients before entering S phase. Phosphorylation-dependent protein degradation may be used to signal completion of previous actions. Another consequence of the multiphosphorylated degron is that each kinase pathway now becomes dependent upon the actions of the other to efficiently target the substrate for degradation.
Cdh1 and its negative regulation of the Skp2 oncogene
The F-box protein Skp2 (Fbl1) is required for degradation of the p27 Cdk inhibitor during S-phase and is essential for proper S-phase progression (Pagano et al., 1995; Carrano et al., 1999) . Moreover, Skp2 has been attributed oncogenic properties including the ability to promote inappropriate T-lymphocyte proliferation in CD4-Skp2 transgenic models, where ectopic expression of Skp2 leads to a loss of p27 and collaborates with PTEN tumor suppressor downregulation (Latres et al., 2001; Yang et al., 2002) . Correspondingly, Skp2 is found to be upregulated in a wide variety of human cancers, including those affecting the breast, lung, colorectal, and prostate tissues (Hershko et al., 2001; Signoretti et al., 2002; Yang et al., 2002; Yokoi et al., 2002 Yokoi et al., , 2004 . Cells expectedly have many ways to regulate Skp2 activity. First, Skp2 expression is cell cycle regulated, with SKP2 βTRCP P P P P P P P P P P P P P P P P P P P P 
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IκBα Figure 1 Multiple kinases regulate the degradation of SCF substrates, including that of b-TRCP. The priming kinase, depicted in italics, first phosphorylates the substrate to prime it for subsequent binding by the second kinase. The second kinase completes formation of the phosphodegron consensus motif (in bold) by phosphorylating residues that can now be directly recognized by b-TRCP. The absence of the priming activity results in an inability for the second kinase to phosphorylate efficiently the phosphodegron, as well as the stabilization of the substrate. The absence of the second kinase activity also prevents efficient substrate turnover, as the phosphodegron motif remains unphosphorylated and unrecognizable by b-TRCP transcription being activated at the G1/S transition, possibly via E2F. Second, as part of an SCF complex, Skp2 is subject to turnover through an autoubiquitination pathway (Wirbelauer et al., 2000) analogous to that seen with other F-box proteins (Zhou and Howley, 1998) . Interestingly, Skp2 autoubiquitination is negatively regulated by Cks1, a Skp2 binding protein that is an essential cofactor for p27 ubiquitination (Wang et al., 2004) . Increased destabilization of Skp2 in response to transforming growth factor-b has been linked to loss of expression of Cks1, whose interaction with Skp2 appears to physically protect it from autoubiquitination (Wang et al., 2004) .
Another recently identified mechanism to regulate Skp2 directly employs APC Cdh1 . The APC comprises approximately 12 subunits, and its regulation is governed by at least two activating subunits Cdc20 (fizzy) and Cdh1 (Hct1 and fizzy related) (reviewed in Harper et al., 2002; Peters, 2002) . Each of the activating subunits confers a different specificity to the APC, and each directly associates with the APC under different cellular conditions. Cdc20 associates with the APC under conditions of high Cdk activity, and Cdh1 activation is prevented by high Cdk activity. Similar to the role of F-box proteins in the SCF complex, these activating subunits can directly engage substrates either by recognition of destruction box motifs by Cdc20 or by KEN boxes in the case of Cdh1.
The activation of APC Cdh1 results from the following sequence of events, much of which was elucidated in yeast models. Elimination of Pds1 by APC Cdc20 -allowing for the segregation of sister chromatids at metaphase -signals the cell to prepare for mitotic exit by initiating the elimination of mitotic cyclin activity (Shirayama et al., 1999) . This is accomplished in two phases. First, APC Cdc20 targets the bulk of cyclins including Clb3 and Clb5. The second phase involves the full activation of APC Cdh1 to govern the virtually complete elimination of Clb2, which is required for cells to exit mitosis (Wasch and Cross, 2002) . Full activation of APC Cdh1 arises by a lowering of overall Cdk activity through APC Cdc20 activity and release of Cdc14 phosphatase through the mitotic exit network and associated pathways (Visintin et al., 1999; Stegmeier et al., 2002) . Furthermore, to smooth the transition from APC Cdc20 to APC Cdh1 , APC Cdh1 is able to mediate the destruction of APC Cdc20 in late mitosis (Prinz et al., 1998; Shirayama et al., 1998) . Targeted proteolysis thus reinforces the feedback loop that ultimately raises APC Cdh1 levels over that of APC Cdc20 Peters, 2002) . Recently, two groups reported a direct role for APC Cdh1 in the degradation of Skp2 and Cks1 ( Figure 2 ) (Bashir et al., 2004; Wei et al., 2004) . Targeting of SCF Skp2 /Cks1 by APC Cdh1 serves to stabilize p27, subsequently leading to the maintenance of G1 phase and blocking premature S-phase initiation. In the presence of a nondegradable form of Skp2, or upon depletion of Cdh1 by RNAi, populations of cells released from nocodazole arrest enter S phase more rapidly, as judged by higher levels of BrdU incorporation.
An interesting question is how do SCF Skp2 /Cks1 levels ever accumulate to sufficiently high levels to promote appropriate S-phase entry, given that proteolysis is such destroys most of the p27 population during S phase, a small fraction of p27 actually relocalizes to the cytoplasm in G1 (Rodier et al., 2001; Ishida et al., 2002) . The accumulation of cytoplasmic p27 occurs through phosphorylation of Ser-10 by hKIS in the nucleus and phosphorylation of Thr-187 by Akt in the cytoplasm to export and retain p27, respectively (Boehm et al., 2002; Fujita et al., 2002; reviewed in Reed, 2002) . The sensitivity of hKIS and Akt to environmental nutrients and mitogens exposes them as prime candidates to be 'liberators of Cdks' through the export of p27 during G1. Consequently, activation of this small pool of nuclear Cdk's may be able to initiate a pathway that could lead to the inactivation of Cdh1 through Cdk phosphorylation, and thus S phase can initiate (Ang and Harper, 2004; Guardavaccaro and Pagano, 2004) . Inhibition of Cdh1 by Emi1, an E2F-regulated gene (Hsu et al., 2002) , is also likely to be involved in the switch mechanism controlling the G1/S transition, but how Emi1 function fits into p27 destruction prior to E2F activation is unclear at present. c-Myc turnover by Fbw7/Ago c-Myc is a basic-helix-loop-helix/leucine zipper (bHLH/ Zip) transcription factor that can form heterodimers with a variety of DNA binding proteins -including Max, Mad, and Mnt -to bind consensus DNA sequences located in 5 0 regulatory regions within promoters (reviewed in Levens, 2003) . All heterodimer complexes in the c-Myc network are capable of binding the well-studied E-box motif (CACGTG). In general, activation of this c-Myc transactivational network regulates expression of target genes to direct cellular growth, proliferation, differentiation, and apoptosis. As expected, c-Myc is often hijacked and upregulated in human cancers such as Burkitt's lymphoma, myeloid and plasma cell leukemia, carcinomas of the breast, cervix, lung, and colon, osteosarcoma, and glioblastoma (reviewed in Spencer and Groudine, 1991) . Although cMyc can be upregulated due to translocation, defects in turnover pathways may also contribute to elevated levels of c-Myc found in cancer. c-Myc is a highly unstable protein and is known to be degraded through the proteasome pathway. Previous studies have implicated phosphorylation of two residues in myc-box I (MB-I) in its turnover (Henriksson et al., 1993; Lutterbach and Hann, 1994; Pulverer et al., 1994) . Phosphorylation on Ser-62 by Erk family kinases is thought to prime c-Myc for phosphorylation by GSK3b on Thr-58, with Thr-58 phosphorylation being central to mitogen-induced c-Myc turnover (Sears et al., 2000) . The critical importance of Thr-58 in controlling c-Myc abundance comes from the finding that this region of cMyc is among the most frequently mutated regions in the protein. Many of the mutations, such as T58I, are known to stabilize dramatically the protein (Bhatia et al., 1993; Bahram et al., 2000; Gregory and Hann, 2000) .
Recent studies have revealed multiple mechanisms controlling c-Myc abundance and activity. Concurrent papers by Kim et al. (2003) and von der Lehr et al. (2003) first demonstrated a role for Skp2 in influencing c-Myc stability, and also surprisingly a role for Skp2 in promoting c-Myc transcriptional activation (reviewed in . Skp2 associates with c-Myc, but in contrast to early expectations, this association occurred through myc-box II (MB-II) and helix-loophelix zipper (HLH-Zip) domains in c-Myc, did not require phosphorylation at Thr-58, and appeared to be phosphorylation-independent. Skp2 overexpression promoted c-Myc ubiquitination in vitro, with a mild effect on c-Myc stability. However, the major effect of Skp2's interaction with c-Myc appeared to be a dramatic activation of c-Myc activity, as assessed in tissue culture cells. This was interesting in view of the fact that Skp2 is an oncogene and could possibly collaborate with c-Myc to promote cell proliferation. Two questions arise: (1) If c-Myc activity requires Skp2, then why is the phenotype of Skp2 null mice relatively mild, and how can its phenotype be largely reversed by deletion of the Skp2 target p27 ? (2) If Skp2 is not involved in the GSK3b-dependent pathway, what E3 Ub-ligase complex controls c-Myc turnover via the phosphorylation-dependent pathway?
While the answer to the first question is still unknown, recent work has established Fbw7/Ago as the primary mechanism for phosphorylation-dependent degradation of c-Myc in Drosophila and human cells via the GSK3b pathway (Moberg et al., 2004; Welcker et al., 2004a; Yada et al., 2004) . Archipelago (ago) in Drosophila and Fbw7 in mammals are the apparent orthologs of budding yeast Cdc4p and recognize related phosphodegrons (Koepp et al., 2001; Nash et al., 2001) . Welcker et al. (2004a) and Yada et al. (2004) found that removal of Fbw7 or overexpression of a dominant-negative form of Fbw7 leads to stabilization of c-Myc. Furthermore, it was shown that Fbw7 directly binds to c-Myc and that this binding is dependent upon Thr-58 phosphorylation by GSK3b. Lastly, SCF Fbw7 promotes GSK3b-dependent c-Myc ubiquitination in vitro. In vitro, c-Myc dually phosphorylated on Thr-58 and Ser-62 binds to Fbw7 and phosphorylation on Ser-62 is required for priming the binding of GSK3b to c-Myc; however, it has recently been proposed that Ser-62 phosphorylation must be removed by PP2A prior to c-Myc ubiquitination (Yeh et al., 2004) . Phosphorylation of Thr-58 and Ser-62 generates a phosphodegron that interacts with Fbw7. This phosphodegron is similar in sequence to that found in cyclin E, which is also recognized by Fbw7 (Figure 2 How then are the activities of Skp2 and Fbw7 toward c-Myc spatially and temporally regulated? It is quite likely, based on the available data, that Skp2 and Fbw7 play opposing roles in c-Myc activity. Skp2 may predominantly function to increase c-Myc activity and this may occur primarily during S phase, when Skp2 levels are the highest. Concomitant with c-Myc activation by Skp2 and ubiquitination is the turnover of cMyc through the proteasome. Conceivably, c-Myc may be activated by ubiquitination and then destroyed after it has engaged in a productive transcription complex. Hence, Skp2 may be targeting only the small fraction of c-Myc in the cell that engages in transcription at that moment. Inherent in this model is that the Skp2-c-Myc interaction occurs on chromatin. In contrast, recent studies indicate that Fbw7 may be selectively ubiquitinating c-Myc within the nucleolus (Welcker et al., 2004b) . The g isoform of Fbw7 is located in the nucleolus of tissue culture cells. Its ablation by RNAi leads to increased cell size and increased accumulation of c-Myc, whereas depletion of the cytoplasmic b form of Fbw7 does not lead to these phenotypes. The importance of the nuclear a isoform is uncertain at the moment. Interestingly, expression of c-Myc bearing a Thr-58 to alanine mutation abrogates the increase in cell size seen with depletion of Fbw7g. Moreover, inhibition of the proteasome leads to the accumulation of c-Myc in the nucleolus. Depletion of Fbw7g by RNAi closely mimics this, indicating that the pathway leading to cMyc degradation in response to phosphorylation by GSK3b involves passage through the nucleolus. Thus, the effects of Skp2 and c-Myc likely occur in different cellular locations, occurs in response to different signals, and appear to have different consequences with respect to c-Myc function.
Fbw7 functions generally in the degradation of oncogenes
Involvement of the SCF Fbw7 complex in phosphorylation-dependent c-Myc turnover is consistent with suggestions of Fbw7 functioning as a recessive tumor suppressor gene (Moberg et al., 2001; Strohmaier et al., 2001; Spruck et al., 2002; Rajagopalan et al., 2004) . Fbw7 further functions in the ubiquitination of other proteins with oncogenic potential. It was first identified in Caenorhabditis elegans as Sel-10, which interacts with LIN-12/Notch proteins to promote their degradation (Hubbard et al., 1997) . In addition to c-Myc and Notch, Fbw7 has also been demonstrated to mediate the degradation of cyclin E (Figure 2) (Koepp et al., 2001; Moberg et al., 2001; Strohmaier et al., 2001) .
Cyclin E and Cdk2 have been implicated in G1/S control, and together, they form a complex that is involved in centrosome duplication, DNA replication, and activation of histone transcription (Reed, 2003; Ye et al., 2003) . Ectopic expression of cyclin E in mammalian cells results in a premature and unusually long S phase, as well as genomic instability. Its oncogenic impact on the cell cycle may be witnessed in its dramatic upregulation in many tumor types, and high cyclin E levels even correlate directly with cancer severity and inversely with patient survival rates (Porter et al., 1997; Strohmaier et al., 2001; Spruck et al., 2002) .
There are at least two pools of cyclin E in the cell, and each is turned over by a different degradation pathway.
Free cyclin E -not bound to Cdk2 -interacts with a Cullin 3-based complex in a phosphorylation-independent manner, and may accordingly control the abundance of free cyclin E throughout the cell cycle (Singer et al., 1999; reviewed in Winston et al., 1999a) . Cul3 forms a modular E3 analogous to the SCF but uses BTB proteins as specificity factors (Furukawa et al., 2003; Geyer et al., 2003; Pintard et al., 2003; Xu et al., 2003) . BTB proteins merge the functional properties of Skp1 and F-box proteins into a single polypeptide chain . The BTB domain adopts a conserved a/b-fold that interacts with Cul3 in a manner similar to that observed with the Skp1/Cul1 complex. BTB proteins often contain additional protein-protein interaction domains that can directly recruit substrates to the Cul3-based SCF (SCF3) complex for ubiquitination. A role for Cul3 in degradation of free cyclin E suggests the involvement of a BTB protein. However, such an adaptor protein has not yet been identified for cyclin E.
The second pool of cyclin E is bound to Cdk2, and it is thus protected from Cul3-mediated turnover (Clurman et al., 1996; Won and Reed, 1996) . Previous studies have implicated SCF Fbw7 in turnover of Cdk2-bound cyclin E and this occurs in a phosphorylation-dependent manner (Koepp et al., 2001; Moberg et al., 2001; Strohmaier et al., 2001) . A major determinant for cyclin E ubiquitination is phosphorylation of Thr-380 (Clurman et al., 1996; Won and Reed, 1996) . Phosphorylation at this site is catalysed by two kinases acting redundantly, Cdk2 and GSK3b (Welcker et al., 2003) . Mutation of Thr-380 to alanine leads to dramatic stabilization of cyclin E and reduces its interaction with Fbw7. In addition, synthetic peptides encompassing Thr-380 are capable of binding tightly to Fbw7 (Koepp et al., 2001) . Cyclin E phosphorylation, however, is complex and it is currently unclear precisely how each of these phosphorylation events contributes to cyclin E regulation and the recognition by Fbw7. At least two additional phosphorylated residues play roles in cyclin E turnover (Strohmaier et al., 2001; Welcker et al., 2003; Ye et al., 2004) . Mutation of T62 to alanine leads to stabilization of cyclin E. This effect appears to be due to both direct and indirect mechanisms. First, cyclin E T62A displays a greatly reduced extent of Thr-380 phosphorylation, as assessed using phospho-specific antibodies (Ye et al., 2004) . Reduced phosphorylation on Thr-380 would be expected to stabilize dramatically cyclin E. However, synthetic peptides encompassing Thr-62 have the capacity to bind to Fbw7, and therefore, in principle, this phosphorylation event could function as a phosphodegron for cyclin E. Indeed, residual association of cyclin E T380 with Fbw7 is abolished when Thr-62 is simultaneously mutated to alanine, consistent with a small direct role for Thr-62 phosphorylation in Fbw7 recognition (Ye et al., 2004) . Additional studies indicate a role for Ser-384 in controlling cyclin E turnover, which is likely phosphorylated by Cdk2 (Welcker et al., 2003; Ye et al., 2004) . Its mutation to alanine stabilizes the protein, although not to the extent seen with Thr-380 mutation. In addition, mutation to alanine reduces the association with both Fbw7a and Fbw7b, without affecting Thr-380 phosphorylation (Ye et al., 2004) . Thus, phosphorylation of at least three residues in cyclin E contributes to its recognition by Fbw7. The kinase involved in phosphorylation of Thr-62 has not been identified, but would be expected to collaborate with Cdk2 and GSK3b in controlling cyclin E abundance. In addition, while all three isoforms of Fbw7 can promote cyclin E turnover in a cotransfection assay, it remains to be determined whether specific Fbw7 isoforms normally regulate endogenous cyclin E turnover.
As mentioned above, cyclin E overexpression has been linked with genomic instability in human cells (Spruck et al., 1999) . Recent studies have demonstrated an analogous phenotype in tissue culture cells that are deleted for the FBW7 gene (Rajagopalan et al., 2004) . Colon cancer cell lines lacking Fbw7 display increased levels of cyclin E expression and genomic instability. To understand the role of Fbw7 in development, two groups created mice lacking the FBW7 gene (Tetzlaff et al., 2004; Tsunematsu et al., 2004) . Mice lacking Fbw7 die at Bday 10 of gestation with multiple abnormalities, including defects in hematopoietic and vascular development, and heart morphogenesis (Tetzlaff et al., 2004; Tsunematsu et al., 2004) . Moreover, placentas from FBW7À/À mice displayed an increased number of giant trophoblast cells undergoing DNA synthesis. These cells displayed increased levels of cyclin E, as expected based on the phenotypes observed with loss of FBW7 in tissue culture cells (Tetzlaff et al., 2004) . In the embryo, evidence for altered expression of notch proteins (particularly Notch-1 and Notch-4), as well as increased levels of expression of notch target genes (Hes1, Herp1, and Herp2), was observed (Tetzlaff et al., 2004; Tsunematsu et al., 2004) . Cyclin E levels were also elevated in the embryo, when reduced levels of CYCLIN E messenger RNA is taken into account (Tetzlaff et al., 2004) . Thus, the available data indicate multiple roles for Fbw7 in controlling the abundance of a number of important signaling molecules including proteins that act as oncogenes.
Regulation of Ub-mediated protein degradation by subcellular localization
In addition to temporal control achieved by having phosphorylation regulate the association of an E3 Ubligase with its substrate, regulation of E3 Ub-ligase activity is similarly sophisticated with regard to its spatial organization and coordination. Subcellular localization is thus implemented to prevent ubiquitination from occurring or to bring together components that will lead to the desired degradation.
Localization of Swe1p and Cdc5 to the septin collar
The regulation of budding yeast Swe1p (Wee1 ortholog), which inhibits the Clb-Cdc28 complex from activating premature mitosis during S and G2 phase, involves subcellular localization. Upon hyperphosphorylation, Swe1p is subject to Ub-mediated degradation (Sia et al., 1998; Sreenivasan and Kellogg, 1999) . However, when there are defects in the formation of the septin collar, Swe1 remains hypophosphorylated and stabilized (Barral et al., 1999; Shulewitz et al., 1999) . This results in an extended G2 phase and elongated cells, as there is a failure to switch from polarized to isotropic growth during budding. This series of events has been referred to as the morphogenetic checkpoint. In a recent paper, Sakchaisri et al. (2004) investigate the kinases involved in Swe1p regulation. They first screen six kinases known to associate with septin filaments at the bud neck, and found that both Cla4 and Cdc5 (Plk1) are capable of additively phosphorylating Swe1 in an in vitro kinase assay. Cdc5 activity is essential for Swe1p degradation in vivo, and in Cdc5-deficient cells, Swe1p remains stabilized at the bud neck. Moreover, a catalytically active Cdc5 truncation mutant (CdcDC) that cannot localize to the bud neck is unable to promote Swe1p degradation, suggesting that the Cdc5 specifically at the neck is responsible for Swe1p turnover. Costaining with tubulin and Cdc5 demonstrated that Cdc5 localizes to the bud neck prior to mitosis, consistent with its role in local Swe1p turnover. Cla4-depleted cells, interestingly, harbored little alterations with regard to Swe1p stability or septin filament assembly when arrested with nocodazole in mitosis. However, when arrested in S phase with hydroxyurea, these Cla4-depleted cells contain hypophosphorylated Swe1p. Together, the data support a role for Cla4 activity in S phase contributing to Cdc5 phosphorylation of Swe1p at the septin ring upon the onset of metaphase. Since Swe1p degradation is confined and localized to the septin ring by first localizing Cdc5, Sakchaisri et al. propose that the septin ring at the bud neck acts as a scaffold or a platform for the sequential phosphorylation and targeted degradation of Swe1 to occur smoothly, accurately, and efficiently (Figure 3a) . The identity of the E3 required for Swe1 turnover is unknown, but in mammalian cells, SCF b-TRCP has been implicated in the turnover of Wee1 upon its phosphorylation by cyclin B-Cdc2 and Plk1 (Watanabe et al., 2004) .
Emi1 degradation at mitotic spindle poles
Emi1 has emerged as a critical regulator of mitotic progression and the G1/S transition through its inhibition of the APC (Reimann et al., 2001) . In mitosis, Ubmediated degradation of Emi1 by SCF b-TRCP allows the activation of APC Cdc20 that leads to mitotic exit (Margottin-Goguet et al., 2003) . Later, at the end of G1, Emi1 expression increases once again through upregulation by E2F (Hsu et al., 2002) . This results in APC Cdh1 inhibition, Skp2 and cyclin A accumulation, p27 degradation, and S-phase entry.
In mammalian cells undergoing mitosis, the kinase activities of cyclin B/Cdk1 and Plk1 have been shown to induce APC Cdc20 activation (reviewed in Harper et al., 2002; Peters, 2002) . While cyclin B/Cdk1directly phosphorylates the APC to promote APC Cdc20 assembly and activation, Plk1 serves a more indirect role in APC activation. Hansen et al. (2004) and Moshe et al. (2004) recently demonstrate that Plk1 catalyses the formation of the Emi1 phosphodegron that is recognized by SCF b-TRCP . The resulting degradation of Emi1 releases the APC from inhibition, and in the presence of cyclin B/ Cdk1 activity, APC Cdc20 accumulates. Both labs establish that mitotically active Plk1 and proper phosphorylation of sequences in Emi1 are capable of binding to the polobox in Plk1. In vitro assays further demonstrate that Plk1 directly binds and phosphorylates Emi1.
Interestingly, Emi1 degradation appears to occur specifically at mitotic spindles (Figure 3b) (Hansen et al., 2004) . In early mitosis, Emi1 localizes to the interchromosomal regions. As mitosis progresses into metaphase, Emi1 undergoes redistribution to the spindle poles. Detailed analysis using confocal immunofluorescence demonstrated that Plk1 accumulates on early mitotic centrosomes and spindle poles (Golsteyn et al., 1994 (Golsteyn et al., , 1995 . Redistribution of Emi1 in metaphase results in its colocalization with Plk1. Upon closer inspection of the interacting proteins using immunofluorescence, Hansen et al. discover that although Emi1 and Plk1 colocalize to the assembling spindle poles, Emi1 appears to be excluded from the exact regions on the centrosomes to where Plk1 localizes. Perhaps, destruction of Emi1 is one of the principle functions of Plk1 in spindle assembly, and may also provide a reason for its localization.
Summary and the impact of Ub-mediated proteolysis
There is no doubt that targeted Ub-mediated proteolysis represents an important regulatory strategy in cell cycle control. It is swift, precise, and can support numerous regulatory inputs simultaneously. The key feature to the selectivity and timing of this degradation pathway lies in the interaction between the E3 Ub-ligase and its targeted substrate. The molecular basis for much of this recognition is still being elucidated, nevertheless there are emerging themes in how E3 Ub-ligases recognize their targets, how they autoregulate and interact with one another in bone fide pathways, and how their activities are controlled in the context of a complex cellular environment. The themes discussed here include a dependency on post-translational modifications to either activate particular E3 Ub-ligases or at the substrate level where multisite phosphorylation mediates formation of the phosphodegron. There is also the realization that E3 Ub-ligases can be networked into complicated pathways to regulate the activities of other E3 Ub-ligases. And lastly, in a complex cellular environment, E3 Ub-ligases benefit from being able to compartmentalize and restrict their activities to particular subcellular regions.
The importance of the Ub degradation pathway may be best witnessed in cases where components of the Ub pathway are misregulated, usually leading to carcinogenesis or developmental defects. Many of these components had been first identified as potent (a) Swe1p localizes to the septin collar following Cla4 phosphorylation, and is possibly tethered there by an Hsl1-Hsl7 complex, so that it can be efficiently phosphorylated by Cdc5. Cdc5 localizes to the septin ring via its C-terminal localization domain. Phosphorylation of Swe1p by Cdc5 results in Swe1p hyperphosphorylation and the creation of a phosphodegron motif that is recognized by an E3 Ub-ligase (b) Emi1 degradation by SCF b-TRCP occurs at the spindle poles during mitosis. Emi1 is first phosphorylated by Cdk activity and then redistributes at metaphase from interchromosomal regions to the spindle poles, likely through direct interaction with the polo-box domain in Plk1. Thus, Plk1 is situated to perform the second round of phosphorylation and promote ubiquitination by SCF b-TRCP oncogenes or tumor suppressors. For example, F-box protein Skp2 is normally absent in postmitotic cells, and as an oncogene, it accumulates to abnormally high levels in a wide variety of cancers, including those found in breast, prostate, colorectoal, and lung tissues (Hershko et al., 2001; Signoretti et al., 2002; Yang et al., 2002; Yokoi et al., 2002 Yokoi et al., , 2004 . In contrast, FBW7 is often found mutated in ovarian and endometrial cancers (Moberg et al., 2001; Strohmaier et al., 2001; Spruck et al., 2002) . There are inevitably many more aspects to be discovered with regard to the mechanisms of how Ub-mediated degradation operates and interacts with other cellular pathways. A grasp of these mechanisms will become imperative in understanding the underlying causes of certain diseases, and perhaps may even provide an avenue for treatment.
